The Food and Drug Administration is scheduled to review a new allergy medication for market approval. The med is a combination of the asthma drug Singulair and the allergy tablet Claritin. Drugmakers Schering-Plough and Merck are seeking approval of the combination for use by patients who have allergic rhinitis.
Read moreAccording to Associated Press business writer Matthew Perrone: Federal health officials said today, that they will add the sternest... Read more »
Late Friday afternoon, January 22, 2010, the Food and Drug Administration (FDA) announced that they approved AMPYRA™ (dalfampridine,... Read more »
(Ivanhoe Newswire) -- Daily treatment with an inhaled steroid is the best way to keep kids with asthma breathing easy. Government researchers arrived... Read more »
Source: HealthCentral Encyclopedia
of asthma can be divided into long-term control and quick-relief medications.Long-term control medications are taken daily to maintain control of... Read more »
Source: Medifocus Guidebook on: Childhood Asthma
Goals of Treatment of Childhood AsthmaThe major goal of asthma management is to maintain normal life with normal lung function. This can be... Read more »
Source: Medifocus Guidebook on: Hay Fever
strategies focus on impeding the function of the IgE antibodies, interruption of the release of antigen-induced autocoids (histamine and eicosanoids)... Read more »
Source: ADAM Encyclopedia
Long-Term Relief MedicationsThese medications are taken on a regular basis to prevent asthma attacks and control chronic symptoms.Inhaled... Read more »